Last Updated2026-06-02

Market View

₹2,192.7(▲0.93%)

Reporting PeriodQ4 FY26

RPGLIFERPGLIFE Forensic Risk Analysis

Name: RPGLIFE Structural Risk Analysis
Creator: Flagium AI
License: https://creativecommons.org/licenses/by-nc-nd/4.0/

Pharmaceuticals

Risk ClassWatch

Market CapN/A

Primary DriverEarnings Quality

Flagium AI Risk Score

21 / 100

+1 QoQ

Deteriorating

Sentinel Insight

Financial profile remains stable for now. Weakness is detected in profitability and earnings quality. This suggests a building risk profile. Risk is increasing at a faster pace.

59.6th %ile (Sector)Accel: +3 Qtrs

Updated2026-06-02

Market View

₹2,192.7▲0.93%

PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

Earnings Quality

+12.2 pts

Balance Sheet Stress

+8.8 pts

Final Composite Risk21 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 0 → 21 over 12 quarters.

Expected Direction

🚨 Escalate

Primary Deterioration Drivers

Margin Compression
Relative Growth Weakness
Operating Leverage Stress

What to Watch Next Quarter

Operating profit margins
Debt growth
Operating cash flow

Active Risk Objects (7)

CriticalHigh

Margin Compression

📊 Earnings QualityAnnualActive for 1 Years

More Detail

Impact Weight15/15

MomentumAccelerating

Last SignalQ3 FY2026

Operating margin declined by 6.2 bps YoY for two consecutive quarters.

"Early signs of margin erosion. Input costs are beginning to eat into core profits."

Profit Collapse

📊 Earnings QualityQuarterlyActive for 2 Qtrs

More Detail

Impact Weight8/15

MomentumAccelerating

Last SignalQ4 FY2026

RPGLIFE: Net Profit collapsed by 74.5% from FY2025 Q4 to FY2026 Q4.

"Earnings quality is under severe pressure. High accruals suggest potential revenue overstatement."

Operating Leverage Stress

📊 Earnings QualityAnnualActive for 1 Years

More Detail

Impact Weight10/15

MomentumAccelerating

Last SignalQ4 FY2026

Expenses are consistently growing faster than revenues, creating operational pressure.

"The balance sheet is heavily over-leveraged. Interest payments are consuming most of the profit."

Cash Conversion Deficit

📊 Earnings QualityAnnualActive for 1 Years

More Detail

Impact Weight6/15

MomentumAccelerating

Last SignalFY2026

RPGLIFE: OCF below Net Profit in 2/3 recent years.

"Cash conversion is dangerously low. Operational cash flow is significantly trailing reported PAT."

Working Capital Expansion

💧 Liquidity & CoverageAnnualActive for 5 Years

More Detail

Impact Weight10/15

MomentumPersistent

Last SignalQ4 FY2026

Working capital expansion detected: Receivable days increased by 5.3%.

"Early signs of working capital expansion. Receivable or inventory days are creeping up."

Relative Growth Weakness

📊 Earnings QualityAnnualActive for 1 Years

More Detail

Impact Weight12/15

MomentumAccelerating

Last SignalQ3 FY2026

Revenue growth consistently lags behind sector median (12.8%).

"Early signs of earnings quality decay. Profitability is being driven by non-core items."

Capex Efficiency Stress

📊 Earnings QualityAnnualActive for 1 Years

More Detail

Impact Weight8/15

MomentumAccelerating

Last SignalQ2 FY2026

Aggressive Capex (17.2%) amidst slow revenue growth (6.9%).

"Early signs of earnings quality decay. Profitability is being driven by non-core items."

Risk Trajectory

Loading Chart

Resilience Matrix

Metric	Value	vs Sector	Signal
Volatility (σ)	4.64	7.70	✅ RESILIENT
Sensitivity (ε_s)	1	1.00	✅ RESILIENT
Escalation Prob.	5%	5%	✅ NEUTRAL
Safety Buffer	+45.0	+47.0	📈 CRITICAL

Forensic Benchmark Context: Pharmaceuticals (n=99 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart

Share Price

Risk Score (0-100)

Market Performance

₹2,192.7(+0.93%)

1M Divergence-6.72%

1 Week-0.95%

1 Month-4.46%

6 Months-0.71%

1 Year+1.96%

2 Year+56.6%

3 Year+186.03%

Sector Average (1M)+2.27%

Sentinel Forensic Assessment

ALGORITHMIC RISK PROFILE • NON-ADVISORY

The risk profile is Early Signals and currently consolidating. Recent structural triggers in earnings quality suggest a building pressure on the underlying framework. Material forensic traces are visible in operational margins and profitability metrics, indicating a progressive erosion of structural stability. Continued monitoring is necessary as risk levels remain above institutional safety parameters.

RPGLIFE • MARKET STRUCTURE

Stage 1 — Accumulation

The company is in a foundational phase. Risk metrics are stabilizing as the company builds a base for potential future fundamental improvement.

Stage Transition Prob.30%

Trend QualityEarly Base

Phase Progression

Phase Progression Score40%

Readiness LabelLow (Early Base Consolidation)

Probability of Advancing30%

CoinTree Momentum

Composite Z-Score+0.0098σ

Improving momentum strength

Universe Rank#979 of 2716

Top 36.05% in momentum strength

Timeframe Sparklines

1W-0.9%

1M-4.5%

6M-0.7%

Weinstein Indicators

150 DMA₹2,154.35

200 DMA₹2,199.23

150 DMA Slope-0.0317%Flat / Basing

Relative Strength+4.78%Leading

Relative Turnover (RTR)3.6483

ParticipationHealthy

PEER COMPARISON

Ranked comparison against sector peers

Risk profile is broadly in line with the Sector Mean (19).

Ticker	Risk Score	Sector %ile	Delta	Flags	Accel	Primary Driver
RPGLIFERPGLIFE	21	60th	+1	7	+3	Earnings QualityWatch
AAREYDRUGSAarey Drugs & Pharmaceuticals Limited	23	63th	-5	20	+0	Balance Sheet StressWatch
AARTIPHARMAarti Pharmalabs Limited	35	81th	0	18	+0	Earnings QualityWatch
ALBERTDAVDAlbert David Limited	37	90th	-8	27	+0	Balance Sheet StressWatch